Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroendocrine Tumors × Colectomy × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Colonic Neoplasms 3 Postoperative Complications 1 Neuroendocrine Tumors 1 Ileus 1 Colorectal Neoplasms 1 Cholecystolithiasis 1 Carcinoma, Hepatocellular 1 Anastomotic Leak 1

Interventions

lutetium Lu 177 dotatate 18 Magnetic Resonance Spectroscopy 10 Everolimus 8 pembrolizumab 7 Specimen Handling 7 Nivolumab 6 Capecitabine 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 surufatinib 4 cabozantinib 4 amino-acid, glucose, and electrolyte solution 4 Octreotide 4 lenvatinib 3 gallium Ga 68 dotatate 3 Temozolomide 3 Ipilimumab 3 Injections 3 Fluorodeoxyglucose F18 3 Cyclophosphamide 3 tislelizumab 2 olaparib 2 lanreotide 2 fludarabine phosphate 2 fludarabine 2 atezolizumab 2 X-Rays 2 Surveys and Questionnaires 2 Phantoms, Imaging 2 PM 01183 2 FAPI-46 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735198 2025-05-20

TNE-IDC-COLE

Hospital Universitari de Bellvitge

Phase NA Recruiting

Neuroendocrine Tumors, Cholecystolithiasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡